Compare SFM & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SFM | ASND |
|---|---|---|
| Founded | 2002 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 12.8B |
| IPO Year | 2013 | 2015 |
| Metric | SFM | ASND |
|---|---|---|
| Price | $79.75 | $213.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 15 |
| Target Price | $138.64 | ★ $256.40 |
| AVG Volume (30 Days) | ★ 2.0M | 716.8K |
| Earning Date | 02-19-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 49.03 | N/A |
| EPS | ★ 5.15 | N/A |
| Revenue | ★ $8,653,696,000.00 | $758,592,045.00 |
| Revenue This Year | $15.28 | $98.90 |
| Revenue Next Year | $9.87 | $83.74 |
| P/E Ratio | $15.47 | ★ N/A |
| Revenue Growth | 16.60 | ★ 97.46 |
| 52 Week Low | $75.75 | $118.03 |
| 52 Week High | $182.00 | $229.94 |
| Indicator | SFM | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 42.55 | 55.24 |
| Support Level | $77.33 | $208.14 |
| Resistance Level | $81.23 | $216.19 |
| Average True Range (ATR) | 1.96 | 9.09 |
| MACD | 0.35 | 0.47 |
| Stochastic Oscillator | 52.37 | 50.30 |
Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.